Lehang Lin

1.2k total citations
18 papers, 855 citations indexed

About

Lehang Lin is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lehang Lin has authored 18 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lehang Lin's work include RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (4 papers) and Ubiquitin and proteasome pathways (4 papers). Lehang Lin is often cited by papers focused on RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (4 papers) and Ubiquitin and proteasome pathways (4 papers). Lehang Lin collaborates with scholars based in China, United States and Singapore. Lehang Lin's co-authors include Dong Yin, De‐Chen Lin, Jinhai Yan, Zi Yin, Yu Zhou, Tingting Ma, Sheng Chen, Bowen Huang, Yiping Zou and H. Phillip Koeffler and has published in prestigious journals such as Nucleic Acids Research, Cancer Research and American Journal Of Pathology.

In The Last Decade

Lehang Lin

17 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lehang Lin China 14 627 377 165 157 128 18 855
Guijuan Luo China 10 443 0.7× 317 0.8× 133 0.8× 94 0.6× 181 1.4× 12 645
Alexandra Drakaki United States 12 430 0.7× 357 0.9× 215 1.3× 94 0.6× 103 0.8× 37 758
Jinwang Wei China 14 446 0.7× 405 1.1× 219 1.3× 74 0.5× 105 0.8× 21 783
Longzi Liu China 11 436 0.7× 337 0.9× 311 1.9× 288 1.8× 148 1.2× 12 878
Zhouhong Ge China 10 565 0.9× 500 1.3× 287 1.7× 196 1.2× 46 0.4× 12 933
Jincai Wu China 12 309 0.5× 185 0.5× 138 0.8× 78 0.5× 126 1.0× 29 566
Ming Quan China 18 584 0.9× 264 0.7× 200 1.2× 59 0.4× 101 0.8× 37 799
Magali Castells France 9 279 0.4× 203 0.5× 254 1.5× 223 1.4× 68 0.5× 9 723
Ninghua Yao China 13 331 0.5× 266 0.7× 117 0.7× 68 0.4× 79 0.6× 43 516
Zuyi Ma China 14 465 0.7× 295 0.8× 262 1.6× 59 0.4× 146 1.1× 41 766

Countries citing papers authored by Lehang Lin

Since Specialization
Citations

This map shows the geographic impact of Lehang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lehang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lehang Lin more than expected).

Fields of papers citing papers by Lehang Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lehang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lehang Lin. The network helps show where Lehang Lin may publish in the future.

Co-authorship network of co-authors of Lehang Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Lehang Lin. A scholar is included among the top collaborators of Lehang Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lehang Lin. Lehang Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Luo, Peng, Yuntan Qiu, Kaishun Hu, et al.. (2025). The SETDB1-PC4-UPF1 post-transcriptional machinery controls periodic degradation of CENPF mRNA and maintains mitotic progression. Cell Death and Differentiation. 32(8). 1413–1427. 1 indexed citations
3.
Shi, Yanmei, et al.. (2025). Pan-cancer oncogenic properties and therapeutic potential of SF3B4. Cancer Gene Therapy. 32(6). 706–720. 1 indexed citations
4.
Qiu, Yuntan, Meng Meng, Jingyuan Zhang, et al.. (2021). RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma. Molecular Therapy — Nucleic Acids. 27. 241–255. 7 indexed citations
5.
Zhang, Heyun, Yongcong Yan, Hua Ye, et al.. (2021). SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters. Cell Death and Disease. 12(8). 731–731. 20 indexed citations
6.
Huang, Yongsheng, Qian Yang, Yueyuan Zheng, et al.. (2021). Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma. Nucleic Acids Research. 49(16). 9246–9263. 17 indexed citations
7.
Zhang, Yin, Yongxin Huang, Bing Yang, et al.. (2020). LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network. Theranostics. 10(23). 10823–10837. 109 indexed citations
8.
Lin, Lehang, Cheng Xu, & Dong Yin. (2020). Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications. Frontiers in Oncology. 10. 549850–549850. 15 indexed citations
9.
Zheng, Dandan, Yuchuan Jiang, Chen Qu, et al.. (2020). Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis. American Journal Of Pathology. 190(11). 2267–2281. 50 indexed citations
10.
Hu, Kaishun, Wenjing Wu, Li‐Min Xie, et al.. (2020). ATM‐Dependent Recruitment of BRD7 is required for Transcriptional Repression and DNA Repair at DNA Breaks Flanking Transcriptional Active Regions. Advanced Science. 7(20). 2000157–2000157. 33 indexed citations
11.
Huang, Yongsheng, Lehang Lin, Zhuojian Shen, et al.. (2020). CEBPG promotes esophageal squamous cell carcinoma progression by enhancing PI3K-AKT signaling.. PubMed. 10(10). 3328–3344. 21 indexed citations
12.
Hu, Kaishun, Wenjing Wu, Yu Li, et al.. (2019). Poly( ADP ‐ribosyl)ation of BRD 7 by PARP 1 confers resistance to DNA ‐damaging chemotherapeutic agents. EMBO Reports. 20(5). 45 indexed citations
13.
Yin, Zi, Tingting Ma, Bowen Huang, et al.. (2019). Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 255 indexed citations
14.
Lin, Lehang & De‐Chen Lin. (2019). Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma. Cancers. 11(8). 1156–1156. 43 indexed citations
15.
Lin, Lehang, Moli Huang, Xianping Shi, et al.. (2018). Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1. Nucleic Acids Research. 47(3). 1255–1267. 56 indexed citations
16.
Lin, De‐Chen, Anand Mayakonda, Huy Q. Dinh, et al.. (2017). Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma. Cancer Research. 77(9). 2255–2265. 148 indexed citations
17.
Zhang, Heyun, Wenbin Li, Pinbo Huang, et al.. (2015). Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma. Oncology Reports. 33(3). 1481–1492. 19 indexed citations
18.
Lin, Lehang, Daria Gaut, Kaishun Hu, et al.. (2013). Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474). International Journal of Oncology. 44(2). 557–562. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guijuan Luo Breakdown of academic impact, for papers by Alexandra Drakaki Breakdown of academic impact, for papers by Jinwang Wei Breakdown of academic impact, for papers by Longzi Liu Breakdown of academic impact, for papers by Zhouhong Ge Breakdown of academic impact, for papers by Jincai Wu Breakdown of academic impact, for papers by Ming Quan Breakdown of academic impact, for papers by Magali Castells Breakdown of academic impact, for papers by Ninghua Yao Breakdown of academic impact, for papers by Zuyi Ma
Rankless by CCL
2026